AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
5 percent lidocaine cream9/11/2023 ![]() THE MANAGEMENT OF SERIOUS ADVERSE REACTIONS MAY REQUIRE THE USE OF RESUSCITATIVE EQUIPMENT, OXYGEN, AND OTHER RESUSCITATIVE DRUGS. WarningsĮXCESSIVE DOSAGE, OR SHORT INTERVALS BETWEEN DOSES, CAN RESULT IN HIGH PLASMA LEVELS AND SERIOUS ADVERSE EFFECTS, PATIENTS SHOULD BE INSTRUCTED TO STRICTLY ADHERE TO THE RECOMMENDED DOSAGE AND ADMINISTRATION GUIDELINES AS SET FORTH IN THIS PACKAGE INSERT. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to other components of Lidocaine Ointment 5%. It is also useful as an anesthetic lubricant for intubation and for the temporary relief of pain associated with minor burns, including sunburn, abrasions of the skin, and insect bites. Lidocaine Ointment 5% is indicated for production of anesthesia of accessible mucous membranes of the oropharynx. Indications and Usage for Lidocaine Ointment In the rhesus monkey arterial blood levels of 18-21 μg/mL have been shown to be threshold for convulsive activity. Objective adverse manifestations become increasingly apparent with increasing venous plasma levels above 6.0 μg free base per mL. Renal dysfunction does not affect lidocaine kinetics but may increase the accumulation of metabolites.įactors such as acidosis and the use of CNS stimulants and depressants affect the CNS levels of lidocaine required to produce overt systemic effects. The half-life may be prolonged two-fold or more in patients with liver dysfunction. Because of the rapid rate at which lidocaine is metabolized, any condition that affects liver function may alter lidocaine kinetics. Studies of lidocaine metabolism following intravenous bolus injections have shown that the elimination half-life of this agent is typically 1.5 to 2.0 hours. Lidocaine crosses the blood-brain and placental barriers, presumably by passive diffusion. Binding is also dependent on the plasma concentration of the alpha-l-acid glycoprotein. At concentrations of 1 to 4 μg of free base per mL, 60 to 80 percent of lidocaine is protein bound. The plasma binding of lidocaine is dependent on drug concentration, and the fraction bound decreases with increasing concentration. The primary metabolite in urine is a conjugate of 4-hydroxy-2,6-dimethylaniline. Approximately 90% of lidocaine administered is excreted in the form of various metabolites, and less than 10% is excreted unchanged. The pharmacological/toxicological actions of these metabolites are similar to, but less potent than, those of lidocaine. N-dealkylation, a major pathway of biotransformation, yields the metabolites monoethylglycinexylidide and glycinexylidide. Biotransformation includes oxidative N-dealkylation, ring hydroxylation, cleavage of the amide linkage, and conjugation. Lidocaine is metabolized rapidly by the liver, and metabolites and unchanged drug are excreted by the kidneys. Lidocaine is also well-absorbed from the gastrointestinal tract, but little intact drug appears in the circulation because of biotransformation in the liver. In general, the rate of absorption of local anesthetic agents following topical application occurs most rapidly after intratracheal administration. Lidocaine may be absorbed following topical administration to mucous membranes, its rate and extent of absorption depending upon the specific site of application, duration of exposure, concentration, and total dosage. These changes may be attributable to a direct depressant effect of the local anesthetic agent on various components of the cardiovascular system. Hemodynamics:Įxcessive blood levels may cause changes in cardiac output, total peripheral resistance, and mean arterial pressure. It is ineffective when applied to intact skin. ![]() Lidocaine Ointment 5% effects local, topical anesthesia. Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. Lidocaine Ointment - Clinical Pharmacology Mechanism of action: Lidocaine Ointment 5% contains lidocaine, which is chemically designated as acetamide, 2-(diethylamino)- N-(2,6-dimethylphenyl)-, and has the following structural formula:Ĭomposition of Lidocaine Ointment 5%: acetamide, 2-(diethylamino)- N-(2,6-dimethylphenyl)-, (lidocaine) 5% in a water miscible ointment vehicle containing polyethylene glycols. See INDICATIONS AND USAGE for specific uses. Lidocaine Ointment 5% contains a local anesthetic agent and is administered topically.
0 Comments
Read More
Leave a Reply. |